Beta-lactamase detection reagent IVD - UK MHRA Medical Device Registration

Beta-lactamase detection reagent IVD is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 195125. The device is manufactured by Coris Bioconcept Srl from Belgium, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Launch Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Beta-lactamase detection reagent IVD

MHRA Device ID: 195125•Ref: 195125

Device Type

In Vitro Diagnostic Device

Devices

Beta-lactamase detection reagent IVD

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Jun 20, 2024

Manufacturer Information

Name

Coris Bioconcept Srl

Address

Crealys Science Park Rue Guillaume Fouquet 11

Gembloux, Namur, Belgium

Created Date

Jun 11, 2024

Authorized Representative

Name

Launch Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Unit 20 Ash Way Thorp Arch Estate

Wetherby, England, United Kingdom

Postcode: LS23 7FA

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Coris Bioconcept Srl (10)

Other Products from Same Authorized Representative (10)

Beta-lactamase detection reagent IVD - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Adenovirus antigen IVD, kit, rapid ICT, clinical

Giardia lamblia antigen IVD, kit, rapid ICT, clinical

Legionella pneumophila antigen IVD, control

Legionella pneumophila antigen IVD, kit, rapid ICT, clinical

Multiple bacteria carbapenemase nucleic acid IVD, control

Respiratory syncytial virus (RSV) antigen IVD, control

Rotavirus antigen IVD, control

Trypanosoma brucei total antibody IVD, kit, rapid ICT, clinical

Blood cell lysis reagent IVD

Adenovirus antigen IVD, control

Hepatitis B virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Human herpesvirus 6 (HHV6) nucleic acid IVD, kit, nucleic acid technique (NAT)

Candida albicans nucleic acid IVD, kit, nucleic acid technique (NAT)

Chikungunya virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Hepatitis C virus nucleic acid IVD, kit, nucleic acid technique (NAT)

HIV1 genotyping IVD, kit, nucleic acid technique (NAT)

Multiple-type tropical pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Adenovirus nucleic acid IVD, kit, nucleic acid technique (NAT)

Cardiovascular disease genetic risk IVD, kit, nucleic acid technique (NAT)

Human papillomavirus (HPV) high risk strain nucleic acid IVD, kit, nucleic acid technique (NAT)